Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in LoansChange in Net LoansDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Riverview Bancorp (RVSB) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Riverview Bancorp (RVSB) over the last 10 years, with Q2 2025 value amounting to $459000.0.

  • Riverview Bancorp's Gains from Investment Securities changed N/A to $459000.0 in Q2 2025 from the same period last year, while for Dec 2025 it was $477000.0, marking a year-over-year change of. This contributed to the annual value of $14310.0 for FY2023, which is 1743.6% down from last year.
  • Riverview Bancorp's Gains from Investment Securities amounted to $459000.0 in Q2 2025.
  • In the past 5 years, Riverview Bancorp's Gains from Investment Securities registered a high of $2.7 million during Q1 2024, and its lowest value of $11000.0 during Q2 2021.
  • In the last 5 years, Riverview Bancorp's Gains from Investment Securities had a median value of $16576.5 in 2021 and averaged $299634.7.
  • In the last 5 years, Riverview Bancorp's Gains from Investment Securities soared by 1907142.86% in 2024 and then crashed by 9932.94% in 2025.
  • Over the past 5 years, Riverview Bancorp's Gains from Investment Securities (Quarter) stood at $17332.0 in 2021, then decreased by 17.44% to $14310.0 in 2022, then fell by 2.17% to $14000.0 in 2023, then skyrocketed by 19071.43% to $2.7 million in 2024, then plummeted by 82.9% to $459000.0 in 2025.
  • Its last three reported values are $459000.0 in Q2 2025, $18000.0 for Q1 2025, and $2.7 million during Q1 2024.